198 related articles for article (PubMed ID: 24182614)
1. Cost-effectiveness of liver cancer screening.
Cucchetti A; Cescon M; Erroi V; Pinna AD
Best Pract Res Clin Gastroenterol; 2013 Dec; 27(6):961-72. PubMed ID: 24182614
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screening.
Kuo MJ; Chen HH; Chen CL; Fann JC; Chen SL; Chiu SY; Lin YM; Liao CS; Chang HC; Lin YS; Yen AM
World J Gastroenterol; 2016 Mar; 22(12):3460-70. PubMed ID: 27022228
[TBL] [Abstract][Full Text] [Related]
3. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
Cadier B; Bulsei J; Nahon P; Seror O; Laurent A; Rosa I; Layese R; Costentin C; Cagnot C; Durand-Zaleski I; Chevreul K;
Hepatology; 2017 Apr; 65(4):1237-1248. PubMed ID: 28176349
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma screening and diagnosis.
Sherman M; Colombo M
Semin Liver Dis; 2014 Nov; 34(4):389-97. PubMed ID: 25369301
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.
Parikh ND; Singal AG; Hutton DW; Tapper EB
Am J Gastroenterol; 2020 Oct; 115(10):1642-1649. PubMed ID: 32530829
[TBL] [Abstract][Full Text] [Related]
6. Economic Implications of Hepatocellular Carcinoma Surveillance and Treatment: A Guide for Clinicians.
Likhitsup A; Parikh ND
Pharmacoeconomics; 2020 Jan; 38(1):5-24. PubMed ID: 31573053
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.
Nouso K; Tanaka H; Uematsu S; Shiraga K; Okamoto R; Onishi H; Nakamura S; Kobayashi Y; Araki Y; Aoki N; Shiratori Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):437-44. PubMed ID: 17683496
[TBL] [Abstract][Full Text] [Related]
8. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
Amarapurkar D; Han KH; Chan HL; Ueno Y;
J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
[TBL] [Abstract][Full Text] [Related]
9. Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it?
Giannini EG; Cucchetti A; Erroi V; Garuti F; Odaldi F; Trevisani F
World J Gastroenterol; 2013 Dec; 19(47):8808-21. PubMed ID: 24379604
[TBL] [Abstract][Full Text] [Related]
10. Screening for hepatocellular carcinoma: survival benefit and cost-effectiveness.
Yuen MF; Lai CL
Ann Oncol; 2003 Oct; 14(10):1463-7. PubMed ID: 14504044
[TBL] [Abstract][Full Text] [Related]
11. Screening and surveillance for hepatocellular carcinoma: perspective of a new era?
Maida M; Malizia G; Affronti A; Virdone R; Maida C; Margherita V; D'amico G
Expert Rev Anticancer Ther; 2016 Dec; 16(12):1291-1302. PubMed ID: 27730841
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of a two-stage screening intervention for hepatocellular carcinoma in Taiwan.
Shih ST; Crowley S; Sheu JC
J Formos Med Assoc; 2010 Jan; 109(1):39-55. PubMed ID: 20123585
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
[TBL] [Abstract][Full Text] [Related]
14. [Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue].
Trinchet JC; Nahon P; Ganne-Carrie N
Rev Prat; 2013 Feb; 63(2):222-5. PubMed ID: 23513790
[TBL] [Abstract][Full Text] [Related]
15. Screening for hepatocellular carcinoma: why, when, how?
Arguedas MR
Curr Gastroenterol Rep; 2003 Feb; 5(1):57-62. PubMed ID: 12530949
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis.
Sarasin FP; Giostra E; Hadengue A
Am J Med; 1996 Oct; 101(4):422-34. PubMed ID: 8873514
[TBL] [Abstract][Full Text] [Related]
17. Domain Analysis of Integrated Data to Reduce Cost Associated with Liver Disease.
Motiwala T; Kite B; Regan K; Gascon GM; Payne PR
Stud Health Technol Inform; 2015; 216():414-8. PubMed ID: 26262083
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis.
Andersson KL; Salomon JA; Goldie SJ; Chung RT
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1418-24. PubMed ID: 18848905
[TBL] [Abstract][Full Text] [Related]
19. Surveillance for hepatocellular carcinoma.
Della Corte C; Colombo M
Semin Oncol; 2012 Aug; 39(4):384-98. PubMed ID: 22846857
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]